Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma
Clinical trial NCT04797182 · UNKNOWN
Trial details
- NCT number
- NCT04797182
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-04-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.